Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse

V. de Haas, W. B. Breunis, O. J. Verhagen, H. van der Berg, C. E. van der Schoot

Research output: Contribution to journalComment/Letter to the editorAcademic

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)1619-1620
JournalBlood
Volume96
Issue number4
Publication statusPublished - 2000

Cite this